Research ReportsJB Chemicals Q1 Results Review - Domestic Business, CMO To Drive Future Growth: Nirmal Bang
ADVERTISEMENT
JB Chemicals Q1 Results Review - Domestic Business, CMO To Drive Future Growth: Nirmal Bang
The five-year average EV/Ebitda of the company is 21x and the brokerage is valuing it at 23x on the back of strong growth in acquired brands and IPM-beating performance.
JB Chemicals & Pharmaceuticals Ltd. (Source: Company website)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.